FDA approves Pfizer-BioNTech COVID-19 vaccine for EUA

January 14, 2021

The Food and Drug Administration (FDA) said it has approved Pfizer-BioNTech's coronavirus vaccine for emergency use authorization (EUA).

''All conditions for the grant of EUA to Pfizer's vaccine are present,'' said FDA Director General Eric Domingo.

The EUA  of two other drug companies for their COVID-19 vaccines are still being reviewed by the FDA. These are AstraZeneca and Gamaleya.

Sinovac, which the Philippines will buy for its vaccination program rollout set February, has yet to submit data on its phase 3 clinical trials to be able to apply for an EUA, said Domingo. DMS